Transcend-NHL Study

Transcend-NHL Study

obr

1 week
1 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Frederick Locke, MD Program Co-Leader, Immunology, Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, provides his impression of the Transcend-NHL study investigating the use of CAR-T cell therapy in diffuse large B-cell lymphoma (DLBCL).
Up Next Autoplay